Gene · 4928
NUP98: nucleoporin 98 and 96 precursor
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. NUP98: nucleoporin 98 and 96 precursor. Genes, record 4928. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/4928
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P52948 | Nuclear pore complex protein Nup98-Nup96 | 1,817 | 22 | Ensembl, GeneID, HGNC |
Source UniProt
Patents6
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 7632 | P52948 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 7669 | P52948 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 7669 | P52948 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 7632 | P52948 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 58929 | P52948 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 161900 | P52948 | Espacenet |
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,955
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | NUP98 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 32 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 31 | 2025 |
| U10CA180899 | Children's Oncology Group Statistics and Data Center | 19 | 2025 |
| U10CA180886 | COG NCTN Network Group Operations Center - Year 11 STAR Act MCI and PEC Supplement | 17 | 2025 |
| ZIASC010378 | Activation of Proto-Oncogenes by Chromosomal Translocation | 16 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 13 | 2025 |
| P30CA014195 | Cancer Center Support Grant (CCSG) | 12 | 2025 |
| R01GM117360 | Molecular Basis of mRNA Export | 10 | 2025 |
| ZIABC010982 | Collaborative Pathways that Lead to Leukemia | 10 | 2025 |
| P01CA066996 | Development of Novel Therapeutic Strategies in Human Leukemias | 9 | 2025 |
1 to 10 of 1,955Source NIH's project files
See all 1,955 nih grantsPapers2,783
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Expandable DNA-origami rings as a nanomechanical platform for studying disordered nucleoporins. | bioRxiv | 2026 | 42818085 | PubTator, text mining | PubMed |
| Inhibition of nucleoporin 214 depletes leukemia stem cells by promoting heme catabolism and lipid peroxidation. | Blood | 2026 | 42640860 | PubTator, text mining | PubMed |
| NUP153 immunoreactivity in neuroendocrine neoplasms supports the diagnosis of NET versus NEC and is modulated by post-translational modifications. | J Neuroendocrinol | 2026 | 42586948 | PubTator, text mining | PubMed |
| The FOLR2-IRF2BP2 axis mediates erythropoiesis impairment by excess folic acid in myelodysplastic neoplasms. | Leukemia | 2026 | 42575953 | PubTator, text mining | PubMed |
| Beyond nuclear export: chromatin-bound XPO1/CRM1 as a transcriptional scaffold. | Int J Hematol | 2026 | 42565971 | PubTator, text mining | PubMed |
| [Analysis of Genetic Characteristics and Clinical Efficacy in Pediatric Acute Myeloid Leukemia with NUP98∷KDM5A Fusion Gene Positive]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2026 | 42544647 | PubTator, text mining | PubMed |
| Pre-transplant measurable residual disease by flow cytometry is an independent prognostic factor in pediatric acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation. | Front Oncol | 2026 | 42539387 | PubTator, text mining | PubMed |
| Nucleoporin 98 Rearrangements in Acute Leukemia: A Genomic Landscape Study. | Hematol Oncol | 2026 | 42522886 | PubTator, text mining | PubMed |
| Role and insights of human papillomavirus E5 oncoprotein in cervical carcinogenesis. | Exp Ther Med | 2026 | 42488338 | PubTator, text mining | PubMed |
| A Unifying Thermodynamic Model for Phase Separation and Aging of Biopolymers. | Adv Sci (Weinh) | 2026 | 42473993 | PubTator, text mining | PubMed |
1 to 10 of 2,783
See all 2,783 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/4928
GET https://conductscience.org/api/genes/v1/4928/grants?page=2